Halozyme Therapeutics Inc
(STU:RV7)
€
66.76
-1.9 (-2.77%)
Market Cap: 7.94 Bil
Enterprise Value: 9.54 Bil
PE Ratio: 27.41
PB Ratio: 41.12
GF Score: 73/100 Halozyme Therapeutics Inc (STU:RV7) Transcripts
- 1